NCT06882135View on ClinicalTrials.gov

HW071021 Monotherapy in Patients With Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

February 28, 2027

Conditions
Advanced Solid Tumors
Interventions
DRUG

HW071021 Tablets

Administered orally at pre-specified doses once or twice daily.

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Wuhan Humanwell Innovative Drug Research and Development Center Limited Company

INDUSTRY